BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate at H.C. Wainwright BioConnect Conference
Jan 7, 2022
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that CEO John Climaco will present at the upcoming H.C. Wainwright BioConnect Conference. The conference is slated for Jan. 10-13, 2022. Interested parties who have registered for the event can view the presentation, which will be virtual, at 7 a.m. ET on Jan. 10. A replay of the webcast will be available in CNSP’s investor section of its website for 90 days.
To view the presentation, visit https://ibn.fm/KkrtX
To view the full press release, visit https://ibn.fm/zqPxZ
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme, an aggressive and incurable form of brain cancer. Additionally, CNS Pharmaceuticals is advancing the development of its WP1244 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small-molecule agents and is believed to be 500 times more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of WP1244 in the treatment of brain, pancreatic and ovarian cancers as well as lymphomas. For more information about the company, please visit www.CNSPharma.com
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Strikes Put Saudi Arabia’s Economy Under Pressure
Deadly attacks on the main Saudi airport add to the challenges facing the country, as it seeks to maintain energy production and keep major events on track.
HMV to close Oxford Street store after three years
HMV says it is looking for a new site in London's West End, but its current site is "unviable".
How to avoid getting stung if you miss credit card payments
People are increasingly falling behind on credit card repayments, so here's the best way to get debt advice.
Healey faces £35bn Budget challenge to meet spending pledges, says think tank
The Institute for Fiscal Studies says the government will need a "top-up" of billions of pounds if it wants to meet its spending plans.
Campaigners claim minister attempting to undermine 'Holiday Hunger Bill'
The education minister has warned it would immediately cost his department £20m a year at a time when it is already struggling to balance its budget.
AI is less regulated than milk, says Microsoft president
Brad Smith calls for global rules on AI, and says the UK is in the "best position" to lead the charge.
Why some have no choice but to pay costly oil prices
The rural communities vulnerable to heating oil prices rises as the weather gets colder.
Documents falsified to evade tax on Abramovich's wealth, BBC finds
Backdated paperwork also made the Russian oligarch’s yachts and mansions disappear from accounts, investigation finds.
China's growth offers opportunity over shock, experts say
After four days touring the frontlines of China's economic evolution, from Xinyu, an age-old manufacturing hub reinventing itself with advanced industries, to the bustling entrepreneurial engine of Wenzhou, the cradle of the country's private sector, a group of former international political leaders and scholars converged in Beijing on Sunday for the Mingde Strategic Dialogue 2026.
Roofing scammers con homeowners out of thousands of pounds
One in 10 scams reported to Citizens Advice relate to fraudsters charging for work not done, or done badly.
Trump faces growing backlash over plans to import diesel from Russia
Both Republican and Democratic lawmakers have criticised the deal, which was announced weeks before the US midterm elections.
Citroen revives the 2CV for an electric age
The French firm is reinventing the classic model as carmakers come under pressure from Chinese rivals.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.